-
Kanamycin A,
often referred to
simply as
kanamycin, is an
antibiotic used to
treat severe bacterial infections and tuberculosis. It is not a
first line...
- In
molecular biology,
kanamycin nucleotidyltransferase EC 2.7.7.- (KNTase) is an
enzyme which is
involved in
conferring resistance to
aminoglycoside antibiotics...
- the 3'-hydroxyl
group of a 4,6-disubstituted aminoglycoside, such as
kanamycin. However, APH(3') has also been
found to
phosphorylate at the 5'-hydroxyl...
-
sugar portion of this
class of
molecules (e.g., the 2-deoxystreptamine in
kanamycins, gentamicins, and tobramycin, see above) are
implicated in the ****ociation...
-
Health Organization's List of
Essential Medicines. It is
derived from
kanamycin.
Amikacin is most
often used for
treating severe infections with multidrug-resistant...
-
genetically modified organism in 1973, a
bacterium resistant to the
antibiotic kanamycin. The
first genetically modified animal, a mouse, was
created in 1974 by...
-
survival and
creation of
biofilms Aminoglycoside antibiotics, such as
kanamycin, gentamicin, streptomycin, were once
effective against staphylococcal...
-
unable to
synthesize proteins vital to its growth.
Gentamicin Garamycin Kanamycin Kantrex Neomycin Neo-Fradin
Netilmicin Netromycin Tobramycin Nebcin Paromomycin...
-
which confers resistance to
certain aminoglycoside antibiotics including kanamycin and neomycin. On May 18, 1994, the FDA
completed its
evaluation of the...
- +
kanamycin-B ⇌ {\displaystyle \rightleftharpoons } CoA + N6'-acetylkanamycin-B Thus, the two
substrates of this
enzyme are acetyl-CoA and
kanamycin B...
